SCHEMBL15057255

SCHEMBL15057255

CN(C)C(=O)C(F)(F)Oc1cc(F)c(N)cc1N

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ G6PD P11413 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ RIPK1 Q13546 1/20 0.31
▸ HSD17B1 P14061 1/20 0.30
▸ HSD17B2 P37059 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15057443 0.84 KDM4E (0.33) NOTUMKDM4EMEN1USP2ALDH1A1
SCHEMBL17875096 0.79 HDAC1 (0.36) ALDH1A1MAPT
SCHEMBL15076282 0.71 — —
SCHEMBL15059514 0.70 FFAR1 (0.39) MEN1MAPTKMT2AL3MBTL1RIPK1
SCHEMBL17875092 0.68 KMT2A (0.33) MEN1ALDH1A1KMT2A
SCHEMBL17875094 0.68 HTT (0.33) MEN1MAPTKMT2AL3MBTL1RIPK1
SCHEMBL15058291 0.67 SLC6A4 (0.35) ALDH1A1THRBRIPK1
SCHEMBL26000918 0.66 MAPT (0.34) NOTUMKDM4EMEN1USP2ALDH1A1
SCHEMBL15057124 0.66 HPGD (0.45) USP2ALDH1A1KMT2ARIPK1
SCHEMBL13832504 0.66 L3MBTL1 (0.52) MEN1ALDH1A1MAPTTHRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3010895-B1 PROCESS FOR MANUFACTURING 4-PROPARGYLATED AMINO-BENZOXAZINONES BASF SE (DE) 2017-08-09 — — EP disclosed
EP-3010895-B1 PROCESS FOR MANUFACTURING 4-PROPARGYLATED AMINO-BENZOXAZINONES BASF SE (DE) 2017-08-09 — — EP disclosed
EP-3184515-A1 PROCESS FOR MANUFACTURING 1,4-BENZOXAZINONES BASF SE (DE) 2017-06-28 — — EP disclosed
US-9518045-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-12-13 — — US disclosed
US-9518045-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-12-13 — — US disclosed
US-9518045-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-12-13 — — US disclosed
EP-2885281-B1 CARBAMAT-BENZOXAZINONES USEFUL FOR PREPARING TRIAZIN-BENZOXAZINONES BASF SE (DE) 2016-12-07 — — EP disclosed
US-9512093-B2 Process for manufacturing 4-propargylated amino-benzoxazinones BASF SE (DE) 2016-12-06 — — US disclosed
US-9512093-B2 Process for manufacturing 4-propargylated amino-benzoxazinones BASF SE (DE) 2016-12-06 — — US disclosed
US-9512093-B2 Process for manufacturing 4-propargylated amino-benzoxazinones BASF SE (DE) 2016-12-06 — — US disclosed
US-20140316131-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2014-10-23 — — US disclosed
US-20140316131-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2014-10-23 — — US disclosed
WO-2014026893-A1 CARBAMAT-BENZOXAZINONES BASF SE (DE) 2014-02-20 — — WO disclosed
WO-2014026928-A1 PROCESS FOR MANUFACTURING BENZOXAZINONES BASF SE (DE) 2014-02-20 — — WO disclosed
WO-2013092858-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092858-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092859-A1 PROCESS FOR MANUFACTURING 4-SUBSTITUTED AMINO-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092856-A1 PROCESS FOR MANUFACTURING BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092856-A1 PROCESS FOR MANUFACTURING BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092859-A1 PROCESS FOR MANUFACTURING 4-SUBSTITUTED AMINO-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140316131-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES CYP2B6, UGT1A6, UGT2B17 NOTUM 3002/4885KDM4E 797/4885MEN1 4407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback